Skip to main content

Birmingham/Solihull CCG

Response from Medicines Management

You are perfectly correct that the national intent is of no great surprise and I am sure that you aware that we have advanced plans to release our policy statements on both Flash and Continuous Glucose Monitoring.  We have always aimed to release them in advance of April and they are largely there bar final sign off from our providers, which we do not anticipate to be a major problem.

The guidance issued last week by NHSE has introduced some delay into the process as we now need to update both of our policies to reflect the revised cohort of eligible patients – they are actually a bit different from the original RMOC criteria and are certainly wider.  I am sure you will agree that it would be improper to release guidance based on the RMOC criteria when these have been superseded with what we should probably term NHSE criteria.

As I am sure you are aware, although we have not formally released our guidance, our providers have been working to the documents and have started to make Flash Glucose Monitoring FlashGM available to patients under the RMOC criteria, which I am sure that Dr Narendran will confirm for you.  Up until now, we have classified FlashGM as ‘red’ meaning that the supply is done directly from the provider rather than by GP prescription, and so our national prescribing data will not reflect the true picture.  Going forward, it is highly likely that our initial assessment and initiation of FlashGM will be done in secondary care and prescribing transferred to primary care in four to six weeks after an interim assessment that the intervention is being used as per the guideline.  At this stage, I have no concerns about us meeting the April deadline for making FlashGM available.

To me, this is fascinating as they've seen that Red Listing is probably not the best way.  Up until this point, I'd always assumed BSol would red list.


The final policy is here.

Comments

Popular posts from this blog

Abbott dX 2022 Barcelona - "Make it Count"

For the past four years I've been invited by Abbott to a conference bringing together people with diabetes from across Europe to discuss various topics.  The first year I was meant to attend, it was my 'man v horse' year (the horse won!), so was unable to attend and then the pandemic hit so two further dX's were held virtually.  I was fortunate to be asked to present at last year's session.  This year's event was back in-person and held in Barcelona, coinciding with the latter part of the ATTD conference.   At this point, I must make it very clear - Abbott invited me to the 2022 European Diabetes Exchange forum (dX), that took place in Barcelona.  I attended this two-day event to connect and interact with inspirational and influential people in the diabetes community.  Abbott paid for my ticket and accommodation. #InvitedbyAbbott.  This is formal and it needs to be - I have not been required to do anything by Abbott as a result of my attendance and I hope that m

4.0!

Took my levels this morning and they were at the magic 4.0mmol/l level (72 in US units)! Had a biscuit in celebration! Latest graph above. Seems less predictable than I thought, but at least I am now generally below 10 most of the time. I believe I am however in the 'Honeymoon Period'. This is the time when the body is still producing a little insulin and therefore your levels are easier to control. I don't think that it lasts long. A thick blanket of snow has fallen during the night. I was meant to be going to London today, but I think I'll give it a miss. My daughter (2) saw the snow and got very excited. She had not been out in snow before. We had an excellent half hour out the front of the house making tracks and getting cold! In my nice warm office now drinking a big mug of tea and looking at the snow continuing to fall. Won't be late home tonight.

Freestyle Liberating

So,what's all the fuss about? Today's graph with two Nutella-covered wraps - no Low Carb here! The Abbott Freestyle Libre is a paradigm-changing piece of medical equipment.  It has been warmly embraced by many of the diabetic community since its launch almost three years ago (its birthday is on 16th October).  So what's all the fuss about and is it justified? In my opinion, yes , but with some important caveats, especially with how you use it and interpret the results.  These are my tips for getting the most out of it: Use it for trends - stop thinking you need to compare it to other meters.  The only reason you should continue to test traditionally is to meet requirements of DVLA.  OK, if you are hypo-unaware, I can see logic in checking.  Yes, it can be 'inaccurate' but that's hard to quantify.  If you're far enough into your journey with diabetes, you should have a fair idea of what the scan is going to show.  If it doesn't match